Cargando…

Dantrolene in the treatment of malignant hyperthermia: a case report

Detalles Bibliográficos
Autor principal:	Islander, Gunilla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139685/ http://dx.doi.org/10.1186/1471-2253-14-S1-A7

Ejemplares similares

Malignant hyperthermia and dantrolene sodium
por: Kim, Ha Jung, et al.
Publicado: (2019)

Intraoperative tachycardia, hypercapnia, hyperthermia and muscle stiffness in a dantrolene unavailability case. Can calcium channel blockers be valuable?
por: Marques, Acílio, et al.
Publicado: (2014)

Malignant hyperthermia when dantrolene is not readily available
por: Gong, Xiaodan
Publicado: (2021)

Malignant hyperthermia: Dantrolene sodium - A must have
por: Sharma, Alok, et al.
Publicado: (2012)

A suspected malignant hyperthermia managed without dantrolene sodium
por: Koo, Bon-Sung, et al.
Publicado: (2014)

Treatment of Malignant Hyperthermia without Dantrolene in a 14-year-old Boy
por: Liu, Shu-Ting, et al.
Publicado: (2017)

French guidelines for the management of malignant hyperthermia
por: Krivosic-Horber, René
Publicado: (2014)

Analysis of malignant hyperthermia results in Padua and Siena
por: Tegazzin, Vincenzo, et al.
Publicado: (2014)

Malignant hyperthermia on ICU – sudden attack of the “snake”
por: Johannsen, Stephan, et al.
Publicado: (2014)

A case of rapid progression of postoperative hyperthermia: Dantrolene or not dilemma?
por: Honardar, Marzieh R., et al.
Publicado: (2016)

A suspected case of malignant hyperthermia that was successfully treated with dantrolene administration via nasogastric tube
por: Kang, Bong Jin, et al.
Publicado: (2012)

Accuracy of the diagnosis of malignant hyperthermia in hospital discharge records
por: Pinyavat, Teeda, et al.
Publicado: (2014)

Malignant hyperthermia testing in probands with NO adverse anesthetic reaction
por: Sterling, Carly, et al.
Publicado: (2014)

Carnitine palmitoyltransferase 2 deficiency, malignant hyperthermia and anesthesia
por: Glauber, Violeta, et al.
Publicado: (2014)

Development and evolution of the MHAUS cognitive aid for malignant hyperthermia
por: Pinyavat, Teeda, et al.
Publicado: (2014)

Gene expression in the context of malignant hyperthermia status and ageing
por: Baines, Kathie Nicoll, et al.
Publicado: (2014)

Malignant hyperthermia as a rare cause of SIRS after cardiac surgery
por: Theuerkauf, Nils, et al.
Publicado: (2014)

Knowledge on malignant hyperthermia: as rare as the disease? A nation wide survey
por: Wolvetang, Timothy, et al.
Publicado: (2014)

RYR1 mutation screening 1992 – 2014: a genetic report on 22 years from the Würzburg MH unit
por: Müller, Clemens R, et al.
Publicado: (2014)

Pharmacokinetics of Dantrolene in the Plasma Exchange Treatment of Malignant Hyperthermia in a 14-Year-Old Chinese Boy: A Case Report and Literature Review
por: Li, Xiaoxiao, et al.
Publicado: (2022)

Malignant hyperthermia mutations and correlation with the severity of the anesthetic complication and the level of the in vitro contracture tests
por: Krivosic-Horber, René, et al.
Publicado: (2014)

Rapid Dantrolene Administration with Body Temperature Monitoring Is Associated with Decreased Mortality in Japanese Malignant Hyperthermia Events
por: Toyota, Yukari, et al.
Publicado: (2023)

Preferential allele amplification leading to RyR1 misgenotyping in a malignant hyperthermia susceptible individual
por: Gonzalez, Asensio, et al.
Publicado: (2014)

Advantage from massive parallel sequencing of RYR1 and CACNA1S in diagnostics of malignant hyperthermia susceptibility
por: Fiszer, Dorota, et al.
Publicado: (2014)

Update of the quality assurance (QA) results of halothane and caffeine analysis of all current participating malignant hyperthermia units
por: Fisher, Nickla, et al.
Publicado: (2014)

Venous Thromboembolism Following Dantrolene Treatment for Neuroleptic Malignant Syndrome
por: Chen, Po-Hao, et al.
Publicado: (2016)

Menopause and hormone replacement therapy: effects on the immune system, arthritis and bone
por: Carlsten, H, et al.
Publicado: (2004)

Emergent Treatment of Neuroleptic Malignant Syndrome Induced by Antipsychotic Monotherapy Using Dantrolene
por: Ngo, Vivian, et al.
Publicado: (2019)

Development of a malignant hyperthermia protocol
por: Yeung, EYH, et al.
Publicado: (2015)

Implementation of sonication and feedback control strategies for targeted hyperthermia in prostate with a commercial MR-guided endorectal ultrasound ablation array
por: Salgaonkar, Vasant, et al.
Publicado: (2015)

Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report
por: Miyazaki, Natsumi, et al.
Publicado: (2021)

Using structured reporting templates in staging pancreatic malignancies
por: Francis, Isaac R, et al.
Publicado: (2015)

100 telephone conversations about malignant hyperthermia
por: Petersen, Bodil, et al.
Publicado: (2014)

Malignant hyperthermia and beyond - a virtual BioBank
por: Underwood, Rosie, et al.
Publicado: (2014)

Effectiveness and independence - different treatments of neurogenic bowel dysfunction in children with myelomeningocele
por: Wide, Peter, et al.
Publicado: (2009)

A scientific basis to determine the best paliative treatment for malignant pleural effusion
por: Hojski, A, et al.
Publicado: (2013)

Video of dantrolene effectiveness on neuroleptic malignant syndrome associated muscular rigidity and tremor
por: Brvar, Miran, et al.
Publicado: (2007)

Current clinical application of dantrolene sodium
por: Yang, Hong Seuk, et al.
Publicado: (2023)

The conservative treatment of congenital scoliosis with hemivertebra: report of three cases
por: Aulisa, AG, et al.
Publicado: (2013)

Spend a penny independent - a multidisciplinary project
por: Mattsson, Gunilla Glad, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_h1psg7alvdh88936feqp7lae7n